Cyprus vs Democratic People's Republic of Korea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cyprus
0.5%
in 2024
Democratic People's Republic of Korea
0.4%
in 2024
Cyprus rank
71st
Democratic People's Republic of Korea rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cyprus
- Democratic People's Republic of Korea
How they compare
Cyprus currently reports 0.5% against 0.4% in Democratic People's Republic of Korea, a difference of 0.1%.
That makes Cyprus's figure about 1.2 times Democratic People's Republic of Korea's.
Across all 10 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 71st and Democratic People's Republic of Korea ranks 74th of 246 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Democratic People's Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.4% | 0.2% | Cyprus |
| 2020s | 0.5% | 0.3% | 0.2% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cyprus or Democratic People's Republic of Korea?
- Cyprus, at 0.5% against 0.4% in Democratic People's Republic of Korea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cyprus and Democratic People's Republic of Korea?
- 0.1%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Democratic People's Republic of Korea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cyprus and Democratic People's Republic of Korea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cyprus ranks 71st and Democratic People's Republic of Korea ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.